34,95 €
34,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
17 °P sammeln
34,95 €
34,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
17 °P sammeln
Als Download kaufen
34,95 €
inkl. MwSt.
Sofort per Download lieferbar
payback
17 °P sammeln
Jetzt verschenken
34,95 €
inkl. MwSt.
Sofort per Download lieferbar

Alle Infos zum eBook verschenken
payback
17 °P sammeln
  • Format: ePub

This is the first book that focuses on the statistical options of HTAs, to fully capture the value of health improvements along with their associated economic consequences. After reading the book, readers will better understand why some health technologies receive regulatory or reimbursement approval while others do not, what can be done to improve the chances of approval, and common shortcomings of submissions for drug and device reimbursement. Supplying an accessible introduction to the various statistical options for different methods in an HTA, the book identifies the links to regulatory and reimbursement decisions for each option.…mehr

  • Geräte: eReader
  • ohne Kopierschutz
  • eBook Hilfe
  • Größe: 1.91MB
Produktbeschreibung
This is the first book that focuses on the statistical options of HTAs, to fully capture the value of health improvements along with their associated economic consequences. After reading the book, readers will better understand why some health technologies receive regulatory or reimbursement approval while others do not, what can be done to improve the chances of approval, and common shortcomings of submissions for drug and device reimbursement. Supplying an accessible introduction to the various statistical options for different methods in an HTA, the book identifies the links to regulatory and reimbursement decisions for each option.

Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.

Autorenporträt
Robert Borden Hopkins, PhD, has been the biostatistician at the Programs for the Assessment of Technology in Health (PATH) Research Institute at McMaster University for the past 10 years and has more than 25 years of experience in health care. His role as the biostatistician continues to include educational support at the graduate level; designing and analyzing systematic reviews; designing, conducting and analyzing clinical studies (field evaluations); conducting economic evaluations, burden of illness studies and health technology assessments and providing peer review for more than 20 academic journals and government agencies. Rob was the lead biostatistician for more than 75 funded research projects worth over $15 million, which generated over 100 peer-reviewed publications and abstracts and 40 technical reports for the government, as well over 200 conference, academic or government presentations. Recent methodological issues explored include handling of missing data in meta-analysis, trials and economic evaluations; network meta- analysis; trial-based economic analysis and cost/burden of illness studies. Rob has presented his research at the following conferences: Society of Medical Decision Making, International Society for Pharmacoeconomics and Outcomes Research, Drug Information Association, Canadian Association for Population Therapeutics, Canadian Agency for Drugs and Technologies in Health (CADTH), Canadian Association for Health Services and Policy Research, Society for Clinical Trials, Health Technology Assessment International, Canadian Statistical Society, American Statistical Society, Canadian Health Economics Association and International Health Economics Association. Ron Goeree, MA, is currently a professor in the Department of Clinical Epidemiology & Biostatistics, Faculty of Health Sciences, at McMaster University in Hamilton, Ontario, Canada, where he is the founding field leader for